Outlook

The U.S. economy, despite being hailed as robust by President Donald Trump, has failed to win over the American voters. President Trump has been enthusiastically promoting the economic progress, pointing to a swift growth in the second quarter, decreasing gas prices, and the successful evasion of a...

The conversational artificial intelligence (AI) company SoundHound AI Inc. (NASDAQ:SOUN) surged over 11% on Tuesday after having the second-highest volume day of 2025. With several positive technical indicators, this particular momentum signaled that the stock may be overbought. What Happened: As...

Dollar Tree Inc. (NASDAQ:DLTR) presented its “5 levers mitigation strategy” to address Donald Trump’s “highly fluid and changing” tariff scenario during its first quarter earnings call and highlighted its impact on second quarter profits. What Happened: The company...

Beyond Meat Inc. (NASDAQ:BYND) missed analyst expectations in the first quarter of the ongoing fiscal year and withdrew its full-year revenue guidance, citing the ongoing economic uncertainties. However, the CEO forecasted a “relatively minimal” tariff impact on the firm. What Happened...

Nike Inc. (NYSE:NKE) reported its worst footwear revenue in over a decade as the company transitions under its new CEO. The athletic footwear and apparel company beat its third-quarter earnings and revenue expectations while issuing a disappointing outlook for the fourth quarter. What Happened:...

Microsoft Corp. (NASDAQ:MSFT) has reduced the storage space for OneDrive and Outlook email for students at McGill University in Montreal, Canada. The changes, prompted by security risks and sustainability concerns, will be implemented starting May 31, 2024. What Happened: According to an...

Signs that the U.S. Securities and Exchange Commission (SEC) will approve a Spot Bitcoin exchange-traded fund (ETF) in January are "very encouraging." That's according to Ark Invest CEO Cathie Wood, who is collaborating with 21Shares on two futures ETF products centered on Ethereum...

The global economy, as depicted in the June 2023's OECD Economic Outlook, is exhibiting signs of improvement — albeit with a fragile upturn and substantial downside risks. There have been positive adjustments in global GDP growth, which is now expected to reach 2.7% in 2023 and...

The Analyst Pablo Zuanic from Cantor Fitzgerald maintained a Neutral rating on High Tide Inc., lowering its 12-month price target to C$2.75 from C$2.80, "given the overall sectoral derating and industry challenges." "High Tide continues to consolidate the Canadian retail...

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, released its results for the third quarter ended May 31, 2022, revealing net revenue increased 88%...

The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS), a leading manufacturer of cannabis products, reported its first-quarter fiscal year 2022 financial results late on Wednesday. Highlights Net revenue grew 26.1% sequentially to $23.2 million from $18.4 million in Q4 2021. Net revenue was primarily...

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00. The Thesis: According to Zuanic, the acquisition of Columbia Care (OTC: CCHWF) fits a logical M&A that is characteristic of the industry's ongoing...

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, kept an Overweight rating for Green Thumb Industries (OTCQX: GTBIF) (GTII.CN), and a price target at $41. The Thesis: In a recent analyst note, Zuanic covered GTI’s results for the fourth quarter of 2021 and its guidance for the first quarter...

The Analyst Pablo Zuanic, from Cantor Fitzgerald, kept Curaleaf (CSE:CURA) (OTCQX: CURLF) among the firm’s top picks in the MSO group, with an Overweight rating and a price target at US$16.50. The Thesis Curaleaf will report December quarter results on March 3. Zuanic assumes the firm will...

Pablo Zuanic, analyst at  Cantor Fitzgerald, offered an updated investment model for OrganiGram (TSE: OGI) (NASDAQ: OGI) for which he maintained an Overweight but lowered the 12-month price target for the stock to C$5.30 from C$5.70, owing to the increased share count. The...